Knocking Out Chloroplastic Aldolases/Rubisco Lysine Methyltransferase Enhances Biomass Accumulation in Nannochloropsis oceanica under High-Light Stress
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25073756 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wensi Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Single-Cell Center, CAS Key Laboratory of Biofuels, Shandong Key Laboratory of Energy Genetics, Qingdao Institute of BioEnergy and Bioprocess Technol…. Hauptthemen laut MEDLINE: Aldehyde-Lyases, Lysine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Natural Science Foundation of China, Postdoctoral Science Foundation of China.
Abstract (Originalsprache)
Rubisco large-subunit methyltransferase (LSMT), a SET-domain protein lysine methyltransferase, catalyzes the formation of trimethyl-lysine in the large subunit of Rubisco or in fructose-1,6-bisphosphate aldolases (FBAs). Rubisco and FBAs are both vital proteins involved in CO2 fixation in chloroplasts; however, the physiological effect of their trimethylation remains unknown. In Nannochloropsis oceanica, a homolog of LSMT (NoLSMT) is found. Phylogenetic analysis indicates that NoLSMT and other algae LSMTs are clustered in a basal position, suggesting that algal species are the origin of LSMT. As NoLSMT lacks the His-Ala/ProTrp triad, it is predicted to have FBAs as its substrate instead of Rubisco. The 18–20% reduced abundance of FBA methylation in NoLSMT-defective mutants further confirms this observation. Moreover, this gene (nolsmt) can be induced by low-CO2 conditions. Intriguingly, NoLSMT-knockout N. oceanica mutants exhibit a 9.7–13.8% increase in dry weight and enhanced growth, which is attributed to the alleviation of photoinhibition under high-light stress. This suggests that the elimination of FBA trimethylation facilitates carbon fixation under high-light stress conditions. These findings have implications in engineering carbon fixation to improve microalgae biomass production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Single-Cell Center, CAS Key Laboratory of Biofuels, Shandong Key Laboratory of Energy Genetics, Qingdao Institute of BioEnergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Li Wei, Ansgar Poetsch
Förderung
- National Key Research and Development Program
- Natural Science Foundation of China
- Postdoctoral Science Foundation of China
- Natural Science Foundation of Shandong, China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- the National Key Research and Development Program
- the Natural Science Foundation of China
- the Postdoctoral Science Foundation of China
Zitieren
APA
Liang, W., Wei, L., Wang, Q., You, W., Poetsch, A., Du, X., Lv, N., & Xu, J. (2024). Knocking Out Chloroplastic Aldolases/Rubisco Lysine Methyltransferase Enhances Biomass Accumulation in Nannochloropsis oceanica under High-Light Stress. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073756
Vancouver
Liang W, Wei L, Wang Q, You W, Poetsch A, Du X, et al. Knocking Out Chloroplastic Aldolases/Rubisco Lysine Methyltransferase Enhances Biomass Accumulation in Nannochloropsis oceanica under High-Light Stress. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073756
BibTeX
@article{Liang2024,
author = {Liang, Wensi and Wei, Li and Wang, Qintao and You, Wuxin and Poetsch, Ansgar and Du, Xuefeng and Lv, Nana and Xu, Jian},
title = {Knocking Out Chloroplastic Aldolases/Rubisco Lysine Methyltransferase Enhances Biomass Accumulation in Nannochloropsis oceanica under High-Light Stress},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25073756}
}
EUVIMED